Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, Professor of Medicine at the University of Central Florida, and at Loma Linda University Health, shared a post on LinkedIn:
“SITC 2025 presentations: excellent representation from our rapidly growing Phase I clinical trial program – including an oral late-breaking presentation! Offering a clinical trial investigating a novel cancer treatment should be considered a preferred standard of care! Adventhealth Cancer Institute, Advent Health Central Florida, Orlando, Florida, with our great team.”
More posts featuring Guru Sonpavde.